Dr. Hopp is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9200 W Wisconsin Ave
Milwaukee, WI 53226Phone+1 414-805-6600Fax+1 414-805-6622
Education & Training
Medical College of Wisconsin Affiliated HospitalsResidency, Obstetrics and Gynecology, 2012 - 2016- Medical College of WisconsinClass of 2012
Certifications & Licensure
OH State Medical License 2014 - 2026
WI State Medical License 2013 - 2025- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Clinical Trials
- Study to Test the Drug Darolutamide Along With the Drugs Leuprolide Acetate and Exemestane in Patients With Recurrent Ovarian Granulosa Cell Tumors Start of enrollment: 2024 Feb 08
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 3 citationsA case series of triplet anti-hormonal therapy in androgen receptor-positive recurrent adult ovarian granulosa cell tumor.Rebekah M Summey, Janet S Rader, Michelle Moh, William Bradley, Denise Uyar
Gynecologic Oncology Reports. 2022-12-01 - 19 citationsA prospective pilot study on the incidence of post-operative lymphedema in women with endometrial cancer.Elizabeth Hopp, Janet L. Osborne, Deborah K. Schneider, Claudia J. Bojar, Denise Uyar
Gynecologic Oncology Reports. 2016-01-01 - 1 citationsCarboplatin, paclitaxel, and pembrolizumab followed by pembrolizumab maintenance for primary treatment of incompletely resected epithelial ovarian cancer.Denise Uyar, Chad M Michener, Erin Bishop, Elizabeth Hopp, Pippa Simpson
Frontiers in Oncology. 2024-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
